MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Arena Pharmaceuticals Company Profile (NASDAQ:ARNA)

Consensus Ratings for Arena Pharmaceuticals (NASDAQ:ARNA) (?)
Ratings Breakdown: 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $5.00 (233.33% upside)

Analysts' Ratings History for Arena Pharmaceuticals (NASDAQ:ARNA)
Show:
DateFirmActionRatingPrice TargetActions
1/27/2016Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2015Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2015RBC CapitalLower Price TargetSector Perform$5.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2015WallachBeth CapitalLower Price TargetBuy$6.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015BMO Capital MarketsReiterated RatingMarket Perform$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015WallachBeth CapitalLower Price TargetBuy$8.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2015Piper JaffrayReiterated RatingOverweight$7.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2015RBC CapitalInitiated CoverageSector Perform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015BMO Capital MarketsReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2014BMO Capital MarketsReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014Credit SuisseInitiated CoverageUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2014WallachBeth CapitalLower Price TargetBuy$9.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2014Wells FargoInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/8/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha